Last updated on October 2017

An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia


Brief description of study

The purpose of this study is to determine the safety and effectiveness of ulocuplumab in combination with low dose cytarabine in the treatment of Newly Diagnosed Acute Myeloid Leukemia (AML).

Clinical Study Identifier: NCT02305563

Contact Investigators or Research Sites near you

Start Over

Site 0031

Local Institution
Los Angeles, CA United States
  Connect »

Gary Schiller, Site 0005

Ucla Center Health Sci
Los Angeles, CA United States
  Connect »

Site 0019

Local Institution
Sacramento, CA United States
  Connect »

Daniel Landau, Site 0022

UF Health Cancer Center at Orlando Health
Orlando, FL United States
  Connect »

Site 0053

Local Institution
Louisville, KY United States
  Connect »

Mohammad Abdul Hay, Site 0037

NYU Langone Medical Center
New York, NY United States
  Connect »

Site 0004

Local Institution
Durham, NC United States
  Connect »

Zartash Gul, Site 0016

University Of Cincinnati
Cincinnati, OH United States
  Connect »

Site 0010

Local Institution
Cleveland, OH United States
  Connect »

Gautam Borthakur, Site 0003

The University Of Texas MD Anderson Cancer Center
Houston, TX United States
  Connect »

Site 0047

Local Institution
Milwaukee, WI United States
  Connect »

Site 0011

Local Institution
Curitiba, Brazil
  Connect »

Site 0012

Local Institution
Porto Alegre, Brazil
  Connect »

Site 0038

Local Institution
Barretos, Brazil
  Connect »

Site 0009

Local Institution
Ribeirao Preto, Brazil
  Connect »

Site 0040

Local Institution
Sao Paulo, Brazil
  Connect »

Site 0044

Local Institution
Halifax, NS Canada
  Connect »

Site 0014

Local Institution
Hong Kong, China
  Connect »

Site 0025

Local Institution
Catania, Italy
  Connect »

Site 0027

Local Institution
Milan, Italy
  Connect »

Site 0024

Local Institution
Napoli, Italy
  Connect »

Site 0026

Local Institution
Roma, Italy
  Connect »

Site 0048

Local Institution
Fukuyama-shi, Japan
  Connect »

Site 0034

Local Institution
Isehara, Japan
  Connect »

Site 0049

Local Institution
Hirakata-shi, Japan
  Connect »

Site 0021

Local Institution
Seoul, Korea, Republic of
  Connect »

Site 0007

Local Institution
Bucharest, Romania
  Connect »

Site 0052

Local Institution
Oradea, Romania
  Connect »

Site 0036

Local Institution
Kaohsiung, Taiwan
  Connect »

Site 0029

Local Institution
New Taipei City, Taiwan
  Connect »

Site 0018

Local Institution
Taichung, Taiwan
  Connect »

Site 0020

Local Institution
Taipei, Taiwan
  Connect »

Site 0028

Local Institution
Taoyuan City, Taiwan
  Connect »